163 related articles for article (PubMed ID: 32458280)
1. Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient.
Hentzien M; Guihot A; de Maindreville D; Tabary T; Brodard V; Vieillard V; Adle-Biassette H; Bani-Sadr F
J Neurovirol; 2020 Aug; 26(4):607-610. PubMed ID: 32458280
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals.
Crossley KM; Agnihotri S; Chaganti J; Rodriguez ML; McNally LP; Venna N; Turbett SE; Gutman M; Morey A; Koralnik IJ; Brew BJ
J Neurovirol; 2016 Aug; 22(4):541-5. PubMed ID: 26727910
[TBL] [Abstract][Full Text] [Related]
3. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.
Gasnault J; Kahraman M; de Goër de Herve MG; Durali D; Delfraissy JF; Taoufik Y
AIDS; 2003 Jul; 17(10):1443-9. PubMed ID: 12824781
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy secondary to hepatitis C virus infection-related T-cell lymphopenia.
Aung AK; Robinson J; Hey P; Lehmann M; Chow Y; Stark RJ; Bosco JJ
Intern Med J; 2019 Jan; 49(1):114-118. PubMed ID: 30680891
[TBL] [Abstract][Full Text] [Related]
5. Progressive multifocal leukoencephalopathy in patients with immunovirological control and at least 6 months of combination antiretroviral therapy.
Dalla-Pozza P; Hentzien M; Allavena C; Doe de Maindreville A; Bouiller K; Valantin MA; Lafont E; Zaegel-Faucher O; Cheret A; Martin-Blondel G; Cotte L; Bani-Sadr F;
AIDS; 2022 Mar; 36(4):539-549. PubMed ID: 34873087
[TBL] [Abstract][Full Text] [Related]
6. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region.
Mubanga E; Patel A; Siddiqi OK; Hanson BA; Dang X; Lakhi S; Mulundu G; Bender N; Koralnik IJ
J Neurovirol; 2019 Aug; 25(4):475-479. PubMed ID: 31028690
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
[TBL] [Abstract][Full Text] [Related]
8. Liver cirrhosis in HIV/HCV-coinfected individuals is related to NK cell dysfunction and exhaustion, but not to an impaired NK cell modulation by CD4
Polo ML; Ghiglione YA; Salido JP; Urioste A; Poblete G; Sisto AE; Martinez A; Rolón MJ; Ojeda DS; Cahn PE; Turk GJ; Laufer NL
J Int AIDS Soc; 2019 Sep; 22(9):e25375. PubMed ID: 31536177
[TBL] [Abstract][Full Text] [Related]
9. Progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+T lymphocytopenia.
Puri V; Chaudhry N; Gulati P; Patel N; Tatke M; Sinha S
Neurol India; 2010; 58(1):118-21. PubMed ID: 20228479
[TBL] [Abstract][Full Text] [Related]
10. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
[TBL] [Abstract][Full Text] [Related]
11. Variable Normalization of Naïve CD4+ Lymphopenia and Markers of Monocyte and T Cell Activation over the Course of Direct-Acting Anti-Viral Treatment of Chronic Hepatitis C Virus Infection.
Auma AWN; Shive CL; Kostadinova L; Anthony DD
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062255
[TBL] [Abstract][Full Text] [Related]
12. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
13. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
[TBL] [Abstract][Full Text] [Related]
14. Evolution of hepatitis C virus in HIV coinfected patients under antiretroviral therapy.
Sede M; Parra M; Manrique JM; Laufer N; Jones LR; Quarleri J
Infect Genet Evol; 2016 Sep; 43():186-96. PubMed ID: 27234841
[TBL] [Abstract][Full Text] [Related]
15. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
[TBL] [Abstract][Full Text] [Related]
16. [New trends in progressive multifocal leukoencephalopathy].
Gasnault J; Taoufik Y
Rev Neurol (Paris); 2006 Jan; 162(1):43-56. PubMed ID: 16446622
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells in hepatitis C: Current progress.
Yoon JC; Yang CM; Song Y; Lee JM
World J Gastroenterol; 2016 Jan; 22(4):1449-60. PubMed ID: 26819513
[TBL] [Abstract][Full Text] [Related]
18. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
[TBL] [Abstract][Full Text] [Related]
19. Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection.
Inui K; Miyagawa H; Sashihara J; Miyoshi H; Tanaka-Taya K; Nishigaki T; Teraoka S; Mano T; Ono J; Okada S
Brain Dev; 1999 Sep; 21(6):416-9. PubMed ID: 10487477
[TBL] [Abstract][Full Text] [Related]
20. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
